검색어 : 통합검색[Chase Nicholas]
총 543건 중 543건 출력
, 51/55 페이지
-
501
- Patterns of PSA versus clinically progressive disease in the E3805 CHAARTED trial.
- Bryce, Alan Haruo; Chen, Yu-Hui; Liu, Glenn; Carducci, Michael Anthony; Jarrard, David Frazier; Garcia, Jorge A.; Dreicer, Robert; Hussain, Maha; Eisenberger, Mario A.; Kohli, Manish; Hahn, Noah M.; Plimack, Elizabeth R.; Vogelzang, Nicholas J.; Picus, Joel; DiPaola, Robert S.; Harshman, Lauren Christine; Sweeney, Christopher; Mayo Clinic, Phoenix, AZ; ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; ; University of Wisconsin Carbone Cancer Center, Madison, WI; ; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; ; University of Wisconsin Hosp and Clinics, Madison, WI; ; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; ; University of Virginia Emily Couric Clinical Cancer Center, Charlottesville, VA; ; Division of Hematology/Oncology, Robert H. Lurie Cancer Center Northwestern University Feinberg School of Medicine, Chicago, IL; ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; ; Mayo Clinic, Rochester, MN; ; Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; ; Fox Chase Cancer Center, Philadelphia, PA; ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; ; Washington University in St. Louis School of Medicine, St. Louis, MO; ; University of Kentucky, Lexington, KY; ; Dana; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.5046-5046)
-
502
- Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
- Frost, Emma D.; Shi, Swanny X.; Byroju, Vishnu V.; Pitton Rissardo, Jamir; Donlon, Jack; Vigilante, Nicholas; Murray, Briana P.; Walker, Ian M.; McGarry, Andrew; Ferraro, Thomas N.; Hanafy, Khalid A.; Echeverria, Valentina; Mitrev, Ludmil; Kling, Mitchel A.; Krishnaiah, Balaji; Lovejoy, David B.; Rahman, Shafiqur; Stone, Trevor W.; Koola, Maju Mathew; Cooper Neurological Institute, Cooper University Health Care, Camden, NJ 08103, USA; Department of Neurology, Montefiore Medical Center, Bronx, NY 10467, USA; Cooper Neurological Institute, Cooper University Health Care, Camden, NJ 08103, USA; Cooper Neurological Institute, Cooper University Health Care, Camden, NJ 08103, USA; Cooper Medical School, Rowan University, Camden, NJ 08103, USA; Cooper Medical School, Rowan University, Camden, NJ 08103, USA; Chase Brexton Health Care, Baltimore, MD 21201, USA; Cooper Neurological Institute, Cooper University Health Care, Camden, NJ 08103, USA; Cooper Neurological Institute, Cooper University Health Care, Camden, NJ 08103, USA; Department of Biomedical Sciences, Cooper Medical School, Rowan University, Camden, NJ 08103, USA; Cooper Neurological Institute, Cooper University Health Care, Camden, NJ 08103, USA; Research and Development Department, Bay Pines VAHCS, Bay Pines, FL 33744, USA; Cooper Medical School, Rowan University, Cam; (Brain sciences, v.14, 2024, pp.1163)
-
503
- Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
- Xiang, Michael; Ma, Ting Martin; Savjani, Ricky; Pollom, Erqi L.; Karnes, R. Jeffrey; Grogan, Tristan; Wong, Jessica K.; Motterle, Giovanni; Tosoian, Jeffrey J.; Trock, Bruce J.; Klein, Eric A.; Stish, Bradley J.; Dess, Robert T.; Spratt, Daniel E.; Pilar, Avinash; Reddy, Chandana; Levin-Epstein, Rebecca; Wedde, Trude B.; Lilleby, Wolfgang A.; Fiano, Ryan; Merrick, Gregory S.; Stock, Richard G.; Demanes, D. Jeffrey; Moran, Brian J.; Huland, Hartwig; Tran, Phuoc T.; Martin, Santiago; Martinez-Monge, Rafael; Krauss, Daniel J.; Abu-Isa, Eyad I.; Alam, Ridwan; Schwen, Zeyad; Pisansky, Thomas M.; Choo, C. Richard; Song, Daniel Y.; Greco, Stephen; Deville, Curtiland; McNutt, Todd; DeWeese, Theodore L.; Ross, Ashley E.; Ciezki, Jay P.; Boutros, Paul C.; Nickols, Nicholas G.; Bhat, Prashant; Shabsovich, David; Juarez, Jesus E.; Chong, Natalie; Kupelian, Patrick A.; Rettig, Matthew B.; Zaorsky, Nicholas G.; Berlin, Alejandro; Tward, Jonathan D.; Department of Radiation Oncology, University of California, Los Angeles; Department of Radiation Oncology, University of California, Los Angeles; Department of Radiation Oncology, University of California, Los Angeles; Department of Radiation Oncology, Stanford University, Stanford, California; Department of Urology, Mayo Clinic, Rochester, Minnesota; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Department of Urology, Mayo Clinic, Rochester, Minnesota; Department of Urology, University of Michigan, Ann Arbor; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; Department of Radiation Oncology, University of Michigan,; (Jama network open, v.4, 2021, pp.e2138550)
-
504
- Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody
- Foon, Kenneth A; Yang, Xiao-Dong; Weiner, Louis M; Belldegrun, Arie S; Figlin, Robert A; Crawford, Jeffrey; Rowinsky, Eric K; Dutcher, Janice P; Vogelzang, Nicholas J; Gollub, Jared; Thompson, John A; Schwartz, Garry; Bukowski, Ronald M; Roskos, Lorin K; Schwab, Gisela M; ; (International journal of radiation oncology, biology, physics, v.58, 2004, pp.984-990)
-
505
- Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- Gilligan, Timothy; Lin, Daniel W.; Aggarwal, Rahul; Chism, David; Cost, Nicholas; Derweesh, Ithaar H.; Emamekhoo, Hamid; Feldman, Darren R.; Geynisman, Daniel M.; Hancock, Steven L.; LaGrange, Chad; Levine, Ellis G.; Longo, Thomas; Lowrance, Will; McGregor, Bradley; Monk, Paul; Picus, Joel; Pierorazio, Phillip; Rais-Bahrami, Soroush; Saylor, Philip; Sircar, Kanishka; Smith, David C.; Tzou, Katherine; Vaena, Daniel; Vaughn, David; Yamoah, Kosj; Yamzon, Jonathan; Johnson-Chilla, Alyse; Keller, Jennifer; Pluchino, Lenora A.; 1Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; ; 2University of Washington/Seattle Cancer Care Alliance; ; 3UCSF Helen Diller Family Comprehensive Cancer Center; ; 4Vanderbilt-Ingram Cancer Center; ; 5University of Colorado Cancer Center; ; 6UC San Diego Moores Cancer Center; ; 7University of Wisconsin Carbone Cancer Center; ; 8Memorial Sloan Kettering Cancer Center; ; 9Fox Chase Cancer Center; ; 10Stanford Cancer Institute; ; 11Fred & Pamela Buffett Cancer Center; ; 12Roswell Park Cancer Institute; ; 13Duke Cancer Institute; ; 14Huntsman Cancer Institute at the University of Utah; ; 15Dana-Farber/Brigham and Women's Cancer Center; ; 16The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; ; 17Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; ; 18The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; ; 19; (Journal of the National Comprehensive Cancer Network : JNCCN, v.17, 2019, pp.1529-1554)
-
506
- Considerations in the development of circulating tumor cell technology for clinical use
- Parkinson, David R; Dracopoli, Nicholas; Petty, Brenda Gumbs; Compton, Carolyn; Cristofanilli, Massimo; Deisseroth, Albert; Hayes, Daniel F; Kapke, Gordon; Kumar, Prasanna; Lee, Jerry SH; Liu, Minetta C; McCormack, Robert; Mikulski, Stanislaw; Nagahara, Larry; Pantel, Klaus; Pearson-White, Sonia; Punnoose, Elizabeth A; Roadcap, Lori T; Schade, Andrew E; Scher, Howard I; Sigman, Caroline C; Kelloff, Gary J; New Enterprise Associates, Menlo Park, CA 94025, USA; Johnson &Johnson, Radnor, PA, 19087, USA; CCS Associates, Mountain View, CA, 94043, USA; Critical Path Institute, Tucson, AZ, 85718, USA; Fox Chase Cancer Center, Philadelphia, PA, 19111, USA; Center for Drug Evaluation Research, US Food & Drug Administration, Silver Spring, MA, 20903, USA; University of Michigan, Ann Arbor, MI, 48109, USA; Covance Genomic Lab, Covance Central Labs, Seattle, WA, 98382, USA; Daiichi-Sankyo Pharma Development, Edison, NJ, 08837, USA; National Cancer Institute, Bethesda, MA, 20892, USA; Georgetown University, Washington, DC, 20007, USA; Veridex, LLC, Raritan, NJ, 08869, USA; EMD Serono, Rockland, MA, 02370, USA; National Cancer Institute, Bethesda, MA, 20892, USA; University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany; Foundation for the National Institutes of Health, Bethesda, MA, 20814, USA; Genentech, South San Francisco, CA, 94080, USA; GlaxoSmithKline, Collegeville,; (Journal of translational medicine, v.10, 2012, pp.138-138)
-
507
- Post hoc analysis of the efficacy of pembrolizumab retreatment after progression of advanced urothelial carcinoma (UC) in KEYNOTE-045 and KEYNOTE-052.
- Castellano, Daniel E.; Balar, Arjun Vasant; O'Donnell, Peter H.; Grivas, Petros; Vaughn, David J.; Powles, Thomas; Vuky, Jacqueline; Lee, Jae-Lyun; Fradet, Yves; Bellmunt, Joaquim; Climent, Miguel Á ngel; Vogelzang, Nicholas J.; Plimack, Elizabeth R.; Gurney, Howard; Hahn, Noah M.; Sternberg, Cora N.; Xu, Jin Zhi; Imai, Kentaro; Homet Moreno, Blanca; De Wit, Ronald; University Hospital October 12, Madrid, Spain; ; Perlmutter Cancer Center, NYU Langone Health, New York, NY; ; The University of Chicago, Chicago, IL; ; University of Washington, Seattle, WA; ; Abramson Cancer Center, Penn Medicine, Philadelphia, PA; ; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; ; Oregon Health & Science University, Portland, OR; ; Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea; ; CHU de Quebec-University of Laval, Quebec City, QC, Canada; ; Beth Israel Deaconess Medical Center/IMIM Research Institute, Harvard Medical School, Boston, MA; ; Valencian Institute of Oncology (IVO Foundation), Valencia, Spain; ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV; ; Fox Chase Cancer Center, Philadelphia, PA; ; Westmead Hospital and Macquarie University Hospital, Sydney, NSW, Australia; ; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD; ; Englander Institute for P; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.40, 2022, pp.512-512)
-
508
- Subcutaneous PAD As Induction Therapy for Patients with Newly Diagnosed Myeloma: A Phase 2 Trial Assessing the Impact of Minimal Residual Disease (MRD) in Patients with Deferred Autologous Stem Cell Transplantation (PADIMAC)
- Popat, Rakesh; Cavenagh, James D; Owen, Roger G; Streetly, Matthew; Schey, Stephen A; Koh, Mickey; Crowe, Josephine; Quinn, Michael F.; D'Sa, Shirley; Virchis, Andres; Cook, Gordon; Crawley, Charles; Pratt, Guy; Cook, Mark; Oakervee, Heather E.; Counsell, Nicholas; Adedayo, Toyin; Evans, Alison; Braganca, Nivette; Smith, Paul; lyons-Lewis, Janet; Rabin, Neil; Yong, Kwee L; University College London Hospitals NHS Foundation Trust, London, United Kingdom; Barts Health NHS Trust, London, United Kingdom; St James's University Hospital, Leeds, United Kingdom; Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom; King's College London, London, United Kingdom; St George's Hospital, London, United Kingdom; United Hospital Bath NHS Trust, Bath, United Kingdom; Belfast City Hospital, Belfast, United Kingdom; Mount Vernon Cancer Centre, Hertfordshire, United Kingdom; Barnet & Chase Farm Hospitals NHS Trust, Herts, United Kingdom; St James's University Hospital, Leeds, United Kingdom; Addenbrooke's Hospital, Cambridge, United Kingdom; Birmingham Heartlands Hospital, Birmingham, United Kingdom; University Hospital Birmingham, Birmingham, United Kingdom; Barts Health NHS Trust, London, United Kingdom; Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom; Cancer Research UK & UCL Cancer Trials Centre, London, Unite; (Blood, v.124, 2014, pp.4745-4745)
-
509
- Where and How Are the Initial Antiepileptic Drugs Administered to Children Who Develop Refractory Status Epilepticus? Results from the Pediatric Status Epilepticus Research Group (pSERG) (P3.006)
- Sanchez Fernandez, Ivan; Abend, Nicholas; Agadi, Satish; Arya, Ravindra; Basu, Rajit; Carpenter, Jessica; Chapman, Kevin; Dean, Nathan; Gaillard, William; Glauser, Tracy; Goodkin, Howard; Jackson, Michele; Mikati, Mohamad; Peariso, Katrina; Rathore, Geetanjali; Tasker, Robert; Topjian, Alexis; Turner, David; Wilfong, Angus; Williams, Korwyn; Loddenkemper, Tobias; Boston Childrens Hospital Boston MA United States; Children's Hospital of Philadelphia Philadelphia PA United States; Houston TX United States; United States; Department of Pediatrics Cincinnati Children´s Hospital Cincinnati OH United States; Children's National Medical Center Washington DC United States; Children'S Hospital Colorado Aurora CO United States; Department of Pediatrics Children´s National Medical Center Washington DC United States; Chevy Chase MD United States; Childrens Hosp Med Ctr Dept of Neuro Cincinnati OH United States; UVA Health Center Charlottesville VA United States; Division of Epilepsy and Clinical Neurophysiology, Department of Neurology Boston Children´s Hospital Boston MA United States; Duke University Medical Center, Division of Pediatric Neurology Durham NC United States; Cincinnati OH United States; Houston TX United States; Boston Children´s Hospital Boston MA United States; The Children´s Hospital of Philadelphia Philadelphia; (Neurology, v.82, 2014, pp.P3.006)
-
510
- Cabozantinib (Cabo) in advanced non-clear cell renal cell carcinoma (nccRCC): A retrospective multicenter analysis.
- Martinez Chanza, Nieves; Bossé , Dominick; Bilen, Mehmet Asim; Geynisman, Daniel M.; Balakrishnan, Archana; Jain, Rohit K.; Bowman, I. Alex; Zakharia, Yousef; Narayan, Vivek; Beuselinck, Benoit; Agarwal, Neeraj; McKay, Rana R.; Hsu, Joann; Shah, Sumit; Tripathi, Abhishek; Lam, Elaine Tat; Rose, Tracy Lynn; Carneiro, Benedito A.; Vogelzang, Nicholas J.; Harshman, Lauren Christine; Dana-Farber Cancer Institute, Boston, MA; ; Ottawa Hospital Cancer Centre, Ottawa, ON, Canada; ; University of Texas MD Anderson Cancer Center, Houston, TX; ; Fox Chase Cancer Center, Philadelphia, PA; ; Michigan State University, East Lansing, MI; ; Indiana University, Baltimore, MD; ; UT Southwestern Medical Center, Dallas, TX; ; University of Iowa Hospitals and Clinics, Holden Comprehensive Cancer Center, Iowa City, IA; ; Penn Medicine Abramson Cancer Center, Philadelphia, PA; ; University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium; ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; ; University of California San Diego, San Diego, CA; ; City of Hope, Duarte, CA; ; Stanford Univ, San Francisco, CA; ; University of Oklahoma, Stephenson Cancer Center, Oklahoma City, OK; ; University of Colorado, Aurora, CO; ; University of North Carolina Hospital, Chapel Hill, NC; ; Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, IL; ; Com; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.4579-4579)
QUICK MENU
